RxDoctor Payments Data

Felipe Ramirez-Terrassa, MD

Orthopaedic Surgery of the Spine · New Orleans, LANPI 1780868802

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (38.7%), food and beverage and entertainment — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Mirus, LLC at 33.6% of the total. Reporting peaked in 2023 at $6,342 and has fallen 96.8% since, to $201 in 2025.

$14,755in general payments, 2019–2025

Across 130 payments — averaging $113.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mirus, LLC$5K
  • Alphatec Spine, Inc$4K
  • Surgalign Spine Technologies, Inc.$2K
  • Globus Medical$1K
  • Integrity Implants Inc. Dba Accelus$599
  • Johnson & Johnson$324
  • plus $2K from 19 others

What the payments were for

  • Consulting fees$1,50010%
  • Travel & lodging$5,71039%
  • Food & beverage$5,28936%
  • Entertainment$2,17015%
  • Other$861%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,755 in reported general payments places this provider in the 55th percentile of 29 orthopaedic surgery of the spine providers in Louisiana.

See all orthopaedic surgery of the spine providers in Louisiana

Medicare billing

Part B allowed, 2024
$112,146
Medicare patients
212
Services billed
1,074

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin161$2,235
Tramadol Hcl173$1,704
Diclofenac Potassium56$853
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen62$844
Methocarbamol32$732
Tizanidine Hcl64$696
Cyclobenzaprine Hcl55$616
Diclofenac Sodium47$555
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen36$449
Celecoxib30$442
Methylprednisolone38$310
Ibuprofen23$251
Pregabalin21$229
Meloxicam19$52

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →